We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$648M
AUM Growth
Cap. Flow
+$657M
Cap. Flow %
101.45%
Top 10 Hldgs %
77.62%
Holding
47
New
47
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$74M
2
C icon
Citigroup
C
+$65.4M
3
MRK icon
Merck
MRK
+$56.9M
4
FLG
Flagstar Bank National Association
FLG
+$54.1M
5
NYT icon
New York Times
NYT
+$53M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 33.79%
2 Healthcare 25%
3 Communication Services 9.35%
4 Energy 6.74%
5 Consumer Staples 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$71.2M 10.99%
+2,678,870
New +$74M
C icon
2
Citigroup
C
$217B
$65.2M 10.07%
+1,360,203
New +$65.4M
NYT icon
3
New York Times
NYT
$12.3B
$59.6M 9.19%
+5,385,808
New +$53M
MRK icon
4
Merck
MRK
$315B
$56.5M 8.71%
+1,274,011
New +$56.9M
FLG
5
Flagstar Bank National Association
FLG
$6.21B
$56.1M 8.65%
+1,335,412
New +$54.1M
ORI icon
6
Old Republic International
ORI
$10.3B
$43.9M 6.78%
+3,412,517
New +$45.2M
MBI icon
7
MBIA
MBI
$333M
$39.5M 6.09%
+2,967,350
New +$37.2M
SEB icon
8
Seaboard Corp
SEB
$4.34B
$39.2M 6.05%
+14,004
New +$38M
PTEN icon
9
Patterson-UTI
PTEN
$3.8B
$37.5M 5.79%
+1,939,880
New +$42.3M
HOLX
10
DELISTED
Hologic
HOLX
$29.8M 4.59%
+1,541,870
New +$32.2M
VOXX
11
DELISTED
VOXX International Corporation Class A
VOXX
$28.7M 4.43%
+2,337,392
New +$24.8M
NTP
12
DELISTED
Nam Tai Property Inc.
NTP
$20.9M 3.23%
+3,736,917
New +$33.5M
STL
13
DELISTED
Sterling Bancorp
STL
$10.6M 1.64%
+1,139,040
New +$10.4M
ASTE icon
14
Astec Industries
ASTE
$1.27B
$4.32M 0.67%
+126,000
New +$4.3M
BP icon
15
BP
BP
$108B
$3.19M 0.49%
+93,525
New +$3.26M
USG
16
DELISTED
Usg
USG
$2.77M 0.43%
+120,000
New +$3.12M
BMY icon
17
Bristol-Myers Squibb
BMY
$124B
$2.48M 0.38%
+55,433
New +$2.41M
NVS icon
18
Novartis
NVS
$293B
$2.15M 0.33%
+33,891
New +$2.21M
FNFG
19
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$1.7M 0.26%
+168,632
New +$1.61M
XOM icon
20
ExxonMobil
XOM
$611B
$1.62M 0.25%
+17,934
New +$1.61M
FFIC
21
DELISTED
Flushing Financial
FFIC
$1.13M 0.17%
+68,479
New +$1.08M
CMCSA icon
22
Comcast
CMCSA
$85B
$1.05M 0.16%
+50,568
New +$1.04M
PHELK
23
DELISTED
PETE HELICOPTERS NON VTG
PHELK
$1.02M 0.16%
+29,780
New +$1.02M
CVX icon
24
Chevron
CVX
$373B
$943K 0.15%
+7,968
New +$963K
DCOM
25
DELISTED
Dime Community Bancshares
DCOM
$899K 0.14%
+58,677
New +$849K

Similar funds

Kahn Brothers Group's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Kahn Brothers Group, which disclosed 47 positions worth $648M. Its ten largest holdings account for 78% of the portfolio.

Its largest position is Pfizer: 2,678,870 shares worth $71.2M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, followed by Healthcare and Communication Services.

  • Kahn Brothers Group's largest Q2 2013 buy was Pfizer: 2,678,870 shares worth $71.2M.
  • Kahn Brothers Group's ten largest holdings make up 78% of its $648M portfolio in Q2 2013.
  • Kahn Brothers Group disclosed 47 positions in Q2 2013, its first 13F filing on record.

Based on Kahn Brothers Group's 13F filing for Q2 2013, filed 9 Aug 2013.